You just read:

Siltuximab Receives CHMP Positive Opinion for Use in the Treatment of Multicentric Castleman's Disease, a Very Rare Blood Disorder

News provided by

Janssen-Cilag International NV

21 Mar, 2014, 13:32 GMT